CMS: All Children’s Hospital failures were widespread

A CMS report found the problems at Johns Hopkins All Children’s Hospital in St. Petersburg, Florida, were more extensive than the pediatric heart unit, The Tampa Bay Times reported.

A new report from the agency, which found more issues with the hospital’s management structure, is the latest from the scandal at the hospital. Late last year, the Tampa Bay Times uncovered a rising death rate in the hospital’s heart unit, and the publication’s investigation led to the resignations of several executives. More recently, the hospital was at risk of losing Medicare funding if it didn’t meet the government’s demands to shape up.

The hospital submitted a plan to correct its issues, which the federal government accepted. Inspectors found the board of trustees failed to oversee infection control, physician competence and quality improvement systems, the Tampa Bay Times found. The hospital also did not track outcomes of individual doctors and had no way to analyze data to monitor quality of care and patient safety.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup